Zurueck zur Suche

Reporte zur Charge J52PN

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

28Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 3 TX 3 FL 2 MA 2 OH 2 GA 2 VA 2 ND 2 UT 1 KY 1 PA 1 CA 1

VAERS 2666238

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

schwer
Staat
-
Alter
16,0
Geschlecht
F
Eingang
04.08.2023
Impfdatum
04.08.2023
Beginn
04.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

Immunization was given patient had a syncope episode to follow. No injuries.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2646606

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

schwer
Staat
UT
Alter
18,0
Geschlecht
M
Eingang
17.06.2023
Impfdatum
17.06.2023
Beginn
17.06.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Disorientation Fall Head injury Loss of consciousness Presyncope Visual impairment Vomiting

Symptomtext

Patient had a vasovagal reaction. Upon passing out he hit the front on his head, just above his right eyebrow on the counter top then fell backwards and hit the back of his head on the ground. He was disoriented for 1-2 minutes before answering questions. Patient continued to report vision changes and experienced multiple episodes of vomiting when EMS was called and patient was transported to the ER for concerns about the head injury.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
ER visit on 06/17/23, IV, IV medication(zofran). no other testing has been done at the time of this report but likely will happen.
Aktuelle Erkrankungen
Patient received HPV and Bexsero vaccines
Vorgeschichte
Migraines with aura
Andere Medikamente
sumatriptan PRN
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2670223

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

moderat
Staat
-
Alter
-
Geschlecht
F
Eingang
11.08.2023
Impfdatum
01.06.2023
Beginn
01.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dyspnoea Feeling abnormal Hypopnoea Loss of personal independence in daily activities Nausea Pain Pain in extremity Pyrexia Sleep disorder Stridor Visual impairment Vomiting

Symptomtext

Fever; Arm pain/arm hurt; nausea; vomiting; Visual changes; Labored breathing; almost hypopnea RR: 9; Arm pain that shoots down arm interfering with daily activities and sleep; Arm pain that shoots down arm interfering with daily activities and sleep; Stridor; This non-serious case was reported by a physician via sales rep and described the occurrence of fever in a 18-year-old female patient who received Men B NVS (Bexsero) (batch number J52PN) for prophylaxis. In JUN-2023, the patient received the 1st dose of Bexsero (left deltoid). In JUN-2023, 1 hr after receiving Bexsero, the patient experienced fever (Verbatim: Fever), pain in arm (Verbatim: Arm pain/arm hurt), nausea (Verbatim: nausea), vomiting (Verbatim: vomiting), visual disturbance (Verbatim: Visual changes), labored breathing (Verbatim: Labored breathing), hypopnea (Verbatim: almost hypopnea RR: 9), activities of daily living impaired (Verbatim: Arm pain that shoots down arm interfering with daily activities and sleep), sleep disturbance (Verbatim: Arm pain that shoots down arm interfering with daily activities and sleep) and stridor (Verbatim: Stridor). The outcome of the fever, pain in arm, nausea, vomiting, visual disturbance, labored breathing, hypopnea, activities of daily living impaired, sleep disturbance and stridor were not reported. It was unknown if the reporter considered the fever, pain in arm, nausea, vomiting, visual disturbance, labored breathing, hypopnea, activities of daily living impaired, sleep disturbance and stridor to be related to Bexsero and Bexsero Pre-Filled Syringe Device. It was unknown if the company considered the fever, pain in arm, nausea, vomiting, visual disturbance, labored breathing, hypopnea, activities of daily living impaired, sleep disturbance and stridor to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 09-AUG-2023 A physician reported that patient received 1st dose of Bexsero and immediately following dose, patient complained that arm hurt and went home and slept. Within an hour patient experienced nausea, vomiting, fever, visual changes (saw rings in field of vision) Stridor, labored breathing, almost hypopnea RR: 9. No rash or tongue swelling, patient says she just felt "out of it", lasted about 6 hours, did not need to go to ER. Arm pain that shoots down arm interfering with daily activities and sleep. Revisit with physician 6 days later due to persistent arm pain, patient had full range of motion, no redness, swelling or erythemia, Physician and patient agree to not receive Dose 2. The reporter agrees to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
Test Date: 202306; Test Name: respiratory rate; Result Unstructured Data: (Test Result:9,Unit:unknown,Normal Low:,Normal High:)
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2665106

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge j52pn

moderat
Staat
FL
Alter
17,0
Geschlecht
F
Eingang
02.08.2023
Impfdatum
31.07.2023
Beginn
31.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia Nausea Neuralgia Pain Paraesthesia Vomiting

Symptomtext

Nausea, Vomiting, body aches which started in the evening after vaccination. Then later in the evening she developed numbness and tingling in the toes. Patient had previously dealt with several months of numbness, tingling, and neuropathic pain in her left leg and left arm which eventually improved after a course of steroids and had been resolved for several months prior to vaccine administration

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Peripheral neuropathy of uncertain etiology, ruling out vasculitis or auto-immune condition
Andere Medikamente
Fuloxetine, Gabapentin, Isibloom, Synthroid
Allergien
Dairy
Vorherige Impfungen
-

VAERS 2657648

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

moderat
Staat
KY
Alter
17,0
Geschlecht
F
Eingang
18.07.2023
Impfdatum
14.07.2023
Beginn
14.07.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Limb injury Migraine Sleep disorder Visual impairment Vomiting

Symptomtext

Same day of vaccine, seemed sore around injection site, 6-7 hours later was hit in the arm at work, hurt worse afterwards. The night of 7-14-2023 red area around injection site and felt worse. On 7-17-2023 woke up with a migraine and prism type vision, changes in OD, vomiting.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Scoliosis
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2655881

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

moderat
Staat
MA
Alter
20,0
Geschlecht
F
Eingang
13.07.2023
Impfdatum
12.07.2023
Beginn
12.07.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Immediate post-injection reaction Paraesthesia Periarthritis

Symptomtext

pt reports tingling in arm once needle placed and frozen shoulder following administration of vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
pt to have ultrasound today
Aktuelle Erkrankungen
-
Vorgeschichte
anxiety
Andere Medikamente
fluoxetine
Allergien
Kiwi allergy
Vorherige Impfungen
-

VAERS 2653099

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

moderat
Staat
PA
Alter
18,0
Geschlecht
M
Eingang
06.07.2023
Impfdatum
05.07.2023
Beginn
05.07.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Mobility decreased Pain in extremity

Symptomtext

Pain in the arm severe enough he cannot lift it. Recommended icing it periodically and taking 600-800mg of ibuprofen as needed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
KNA
Vorherige Impfungen
-

VAERS 2649848

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

moderat
Staat
FL
Alter
18,0
Geschlecht
F
Eingang
27.06.2023
Impfdatum
26.06.2023
Beginn
27.06.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Activated partial thromboplastin time normal Blood glucose normal Blood lactic acid normal Blood magnesium Chest pain Chills Dizziness Full blood count abnormal Lipase normal Metabolic function test Mononucleosis heterophile test negative Neutrophil percentage increased Pregnancy test negative Prothrombin time normal Respiratory viral panel Troponin normal White blood cell count increased

Symptomtext

Patient returned about 2 hours after vaccine complaining of chills, chest pain, dizziness and light headedness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
Pregnancy test, RVP, mono spot- negative PT, PTT, troponin, lipase, lactic acid- normal CBC showed elevated WBC count of 19.3 with 95% neutrophils, CMP normal except glucose on 109, magnesium slightly low at 1.5
Aktuelle Erkrankungen
no
Vorgeschichte
none
Andere Medikamente
none
Allergien
chlorhexidine, codeine, latex, mastisol
Vorherige Impfungen
-

VAERS 2707903

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

mild
Staat
-
Alter
-
Geschlecht
F
Eingang
01.11.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Injection site discolouration Injection site rash

Symptomtext

developed a rash at the injection site; black dot at the site; This non-serious case was reported by a other health professional via other manufacturer and described the occurrence of injection site rash in a female patient who received Men B NVS (Bexsero) (batch number J52PN) for prophylaxis. On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced injection site rash (Verbatim: developed a rash at the injection site) and injection site discoloration (Verbatim: black dot at the site). The outcome of the injection site rash was resolved and the outcome of the injection site discoloration was not resolved. It was unknown if the reporter considered the injection site rash and injection site discoloration to be related to Bexsero and Bexsero Pre-Filled Syringe Device. It was unknown if the company considered the injection site rash and injection site discoloration to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-OCT-2023 The reporter stated patient administered the Men B vaccine and developed rash at the injection site. The patient went to urgent care as it was getting bigger on the skin. The reporter stated it was now healed. The patient still had a black dot at the site. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site discolouration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2694966

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

mild
Staat
OH
Alter
24,0
Geschlecht
F
Eingang
12.10.2023
Impfdatum
08.10.2023
Beginn
08.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain in extremity Skin warm Swelling

Symptomtext

Left arm pain, swelling, warm to touch.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
Pfizer

VAERS 2683499

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

mild
Staat
MI
Alter
18,0
Geschlecht
F
Eingang
19.09.2023
Impfdatum
05.09.2023
Beginn
05.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Immediate post-injection reaction Pain in extremity

Symptomtext

pain in left arm immediately following injection and pain continues for three weeks after injection. no redness, swelling, warm to touch, fever.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2674923

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

mild
Staat
TX
Alter
18,0
Geschlecht
F
Eingang
22.08.2023
Impfdatum
23.06.2023
Beginn
23.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Nausea Pain in extremity Pharyngeal swelling Pyrexia Stridor Visual impairment Vomiting

Symptomtext

She got her vaccine, mother called and said she had fever within an hour of getting the vaccine. She also had arm pain, nausea, vomiting, visual changes, stridor. Mom was advised by the clinic by one of the doctors, who reassured the mother that these were reactions to the vaccine, fever can last up to 2 days, but should be better by tomorrow. Patient should hydrate, take Ibuprofen and advised to take to ER if she was having swelling of throat, and other symptoms. Mom voiced understanding. The symptoms resolved as far as the clinic is aware. The arm pain did continue until 6/29/23 when they saw her in the clinic for that. Was told to use Ibuprofen or Tylenol for pain or a topical patch. The clinic did not get any other calls after that.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nausea
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
Bronchitis
Vorgeschichte
None.
Andere Medikamente
Fluoxetine 10 mg, Estarylla, Epiduo gel.
Allergien
None.
Vorherige Impfungen
-

VAERS 2668561

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

mild
Staat
CA
Alter
17,0
Geschlecht
M
Eingang
09.08.2023
Impfdatum
07.07.2023
Beginn
07.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Back pain Fatigue Injection site pain Spinal pain

Symptomtext

Patient experienced soreness in the mid-point of his back/spine beginning the night of the first injection. He felt this predominantly when sitting (vs walking). The type of pain was similar to the injection site (of which we expected the injection site, but not the back), along with significant fatigue. The back pain site dissipated after a couple of days, and the injection site pain took longer to dissipate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none noted
Vorgeschichte
none
Andere Medikamente
none
Allergien
nkda mild environmental allergies
Vorherige Impfungen
-

VAERS 2662649

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

mild
Staat
GA
Alter
18,0
Geschlecht
F
Eingang
28.07.2023
Impfdatum
19.07.2023
Beginn
25.07.2023
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site cellulitis Injection site rash Injection site warmth Rash erythematous

Symptomtext

Approx 1 week after receiving the vaccine patient developed a red rash around the injection site and extending halfway down the upper arm. Patient reported rash was warm to the touch. Patient went to urgent care and was given an antibiotic for presumed cellulitis. After 24 hrs on antibiotic, rash reportedly improving.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site cellulitis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2657780

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

mild
Staat
TX
Alter
17,0
Geschlecht
F
Eingang
18.07.2023
Impfdatum
10.07.2023
Beginn
14.07.2023
Tage bis Beginn
4,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Lip swelling Urticaria

Symptomtext

Symptoms Patient received Men B vaccine on 7/10 -- and then had hives on 7/14/2023 after going out to dinner. Mother gave patient allegra on the 7/14 -- then benedryl the next day and had about 75 % resolution of hives. Mother has added some pepcid as well. Patient did have swollen lips about 2 days after the initial hives, but no swelling inside of mouth/throat. Patient has been taking benedryl about every 6 hours. Last benedryl was at about 8:30 a.m. today. Mother had a similar reaction to the covid vaccine. This patient and her sister did not have any issues with covid vaccines. Patient hasn't had any new products or foods prior to the hives. No fever, cough, congestion, emesis, diarrhea..

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
No labs done
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2657520

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

mild
Staat
NY
Alter
17,0
Geschlecht
M
Eingang
17.07.2023
Impfdatum
11.07.2023
Beginn
17.07.2023
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Erythema Injection site erythema Injection site pain Injection site warmth

Symptomtext

Developed red, warm, tender area ~8x6cm outer left upper arm - indurated 6 days following vaccine administration

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2653102

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

mild
Staat
WI
Alter
18,0
Geschlecht
F
Eingang
06.07.2023
Impfdatum
03.07.2023
Beginn
03.07.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Erythema Headache Injection site erythema Injection site pain Lethargy Pyrexia

Symptomtext

Patient presents with complaints of feeling lethargic, and with low energy after getting the Bexsero vaccine on 07/03/2023. Within hours she developed pain and redness at the site of the injection. Cool compresses were applies. She does take Xyzal nightly. Ibuprofen was taken for a headache that developed. She does have a history of Migraines and Imitrex was given even though she didn't feel it was consistent with her typical migraine. The Imitrex wasn't effective. She proceeded with alternating Tylenol and Ibuprofen. The headache has improved. She take Benadryl which didn't change the erythema, in fact it's now migrating to the axilla. A fever developed today. Tmax was 102 degrees F. She did not have a reaction or similar symptoms after getting Bexsero #1 on 06/24/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
Chronic daily headache 04/13/2023 Priority: Medium ? Migraine without aura and without status migrainosus, not intractable 04/13/2023 Priority: Medium ? Neurocardiogenic pre-syncope 08/15/2022 Priority: Low ? Anxiety disorder of adolescence 06/24/2022 Priority: Low ? Dysmenorrhea in the adolescent 06/24/2022 Priority: Low ? Vitamin D insufficiency 10/07/2020 Priority: Low ? Major depressive disorder with single episode, in full remission 10/06/2020 Priority: Low ? Allergic rhinitis 05/03/2019 Priority: Low Dogs and seasonal ? Intrinsic atopic dermatitis 05/03/2019 Priority: Low ? Mild intermittent asthma without complication 05/30/2018
Andere Medikamente
levocetirizine (XYZAL) 5 MG tablet Take 1 tablet by mouth every evening. montelukast (Singulair) 10 MG tablet Take 1 tablet by mouth daily. albuterol 108 (90 Base) MCG/ACT inhaler Inhale 2 puffs into the lungs every 4 hours as needed for Sh
Allergien
Bactrim DS
Vorherige Impfungen
-

VAERS 2650980

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge j52pn

mild
Staat
TX
Alter
17,0
Geschlecht
F
Eingang
29.06.2023
Impfdatum
01.06.2023
Beginn
27.06.2023
Tage bis Beginn
26,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cellulitis Headache Pyrexia

Symptomtext

Headache and fever day 2. Day 4 post injection developed cellulitis. Required antibiotics and steroid course. NSAIDs and ice packs.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2648395

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

mild
Staat
VA
Alter
17,0
Geschlecht
F
Eingang
22.06.2023
Impfdatum
21.06.2023
Beginn
21.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cellulitis Injection site erythema Injection site pain Injection site swelling Pain Pruritus

Symptomtext

Patient arm felt itchy after vaccination and noticed small area of redness at injection site. This AM redness developed into a 2 1/4 wide x 1.5 L erythematous, tender, raised area at injection site and pain with moving arm. Treated for suspected cellulitis with cephalexin 500 mg BID x 7 days. Ibuprofen for pain. advised to apply topical hydrocortisone cream for itchiness -prescribed on 6/22/23

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
Food allergies
Andere Medikamente
-
Allergien
Peanut, tree nuts, sesame seed, & coconut flavor
Vorherige Impfungen
-

VAERS 2646542

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

mild
Staat
MA
Alter
18,0
Geschlecht
M
Eingang
16.06.2023
Impfdatum
09.06.2023
Beginn
09.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Neck pain

Symptomtext

Headaches; Neck pain; This non-serious case was reported by a physician via call center representative and described the occurrence of headache in a 18-year-old male patient who received Men B NVS (Bexsero) (batch number J52PN, expiry date 31-MAR-2024) for prophylaxis. On 09-JUN-2023, the patient received Bexsero (left arm). On 09-JUN-2023, less than a day after receiving Bexsero, the patient experienced headache (Verbatim: Headaches) and neck pain (Verbatim: Neck pain). The outcome of the headache and neck pain were not resolved. It was unknown if the reporter considered the headache and neck pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device. It was unknown if the company considered the headache and neck pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 14-JUN-2023 The patient received Bexsero at the medical office and experienced headaches and neck pain since the night of the same day. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2702541

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge j52pn

gering
Staat
OH
Alter
11,0
Geschlecht
M
Eingang
26.10.2023
Impfdatum
25.10.2023
Beginn
25.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event

Symptomtext

No reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2701447

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

gering
Staat
GA
Alter
17,0
Geschlecht
M
Eingang
25.10.2023
Impfdatum
24.10.2023
Beginn
24.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hypotonia Immediate post-injection reaction Pallor Snoring

Symptomtext

Immediately after vaccine was administered patient's body became limp, eyes closed and patient began to snore, with skin color becoming pale. Mother was able to awaken patient after approximately 3 seconds. Writer had a tech sit with patient while getting provider that had seen patient in clinic. Provider assessed patient in immunization room. Patient was able to verbalize communication and after sitting in room for over ten minutes was able to stand and walk on his own out of clinic with mother.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypotonia
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
seizure disorder
Vorgeschichte
seizure disorder
Andere Medikamente
keppra 1000 mg
Allergien
none
Vorherige Impfungen
-

VAERS 2690524

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

gering
Staat
MI
Alter
12,0
Geschlecht
M
Eingang
04.10.2023
Impfdatum
18.09.2023
Beginn
18.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administration error Wrong product administered

Symptomtext

The patient was being seen for a well visit. The Medical Assistant placed an order in his EMR for Bexsero instead of Menveo. The doctor who reviewed the patient's order did not catch the error and signed the order. Bexsero was administered instead of Menveo (the required vaccine). The parent was notified and the patient was scheduled to return to the clinic for the correct vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administration error
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE KNOWN
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2687390

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

gering
Staat
IN
Alter
18,0
Geschlecht
F
Eingang
27.09.2023
Impfdatum
15.09.2023
Beginn
15.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Interchange of vaccine products

Symptomtext

Bexsero administered as 2nd dose of Trumenba.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of interchange of vaccine products in a 18-year-old female patient who received Men B NVS (Bexsero) (batch number J52PN, expiry date 31-MAR-2024) for prophylaxis. Co-suspect products included MENINGOCOCCAL B VACCINE (TRUMENBA) for prophylaxis. On 15-SEP-2023, the patient received Bexsero. On an unknown date, the patient received TRUMENBA. On 15-SEP-2023, an unknown time after receiving Bexsero, the patient experienced interchange of vaccine products (Verbatim: Bexsero administered as 2nd dose of Trumenba.). The outcome of the interchange of vaccine products was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-Sep-2023 The pharmacist called to inform that a patient received a dose of Bexsero, but such patient had already received a dose of Trumenba which led to interchange of vaccine products. The reporter consented to follow up. The vaccine administration facility is the same as primary reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2665123

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

gering
Staat
ND
Alter
11,0
Geschlecht
F
Eingang
02.08.2023
Impfdatum
02.08.2023
Beginn
02.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Wrong product administered

Symptomtext

Provider and Mom were both notified of Men B being given inadvertently. Patient had no side effects or reactions at time of call. Mom was informed to let us know if anything appears.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Nasal Congestion and Stomach Ache
Vorgeschichte
None
Andere Medikamente
Multivitamin
Allergien
None
Vorherige Impfungen
-

VAERS 2654269

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

gering
Staat
ND
Alter
16,0
Geschlecht
F
Eingang
10.07.2023
Impfdatum
06.07.2023
Beginn
01.07.2023
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product preparation error

Symptomtext

Nurse did not mix the proper diluent with the powder. No treatment needed. Mother notified. No signs of any complications from client. Will plan on administrating MVC4 again at next months appointment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
N/A
Allergien
KNA
Vorherige Impfungen
-

VAERS 2650550

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge J52PN

gering
Staat
VA
Alter
-
Geschlecht
F
Eingang
28.06.2023
Impfdatum
22.06.2023
Beginn
22.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Syringe issue

Symptomtext

patient received only a half of the dose of Bexsero due to a syringe leak; syringe leak; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete dose administered in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number J52PN, expiry date 31-MAR-2024) for prophylaxis. On 22-JUN-2023, the patient received Bexsero. On 22-JUN-2023, an unknown time after receiving Bexsero, the patient experienced incomplete dose administered (Verbatim: patient received only a half of the dose of Bexsero due to a syringe leak) and syringe leak (Verbatim: syringe leak). The outcome of the incomplete dose administered and syringe leak were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 22-Jun-2023 The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow-up. Earlier on the day of reporting, a patient received only a half of the dose of Bexsero due to a syringe leak, which led to incomplete dose administered and syringe leak.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2648468

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge j52pn

gering
Staat
MI
Alter
17,0
Geschlecht
F
Eingang
22.06.2023
Impfdatum
22.06.2023
Beginn
22.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fall Flushing

Symptomtext

told mom to wait 5-10 minutes make her she does not have a reaction as I (MA) was leaving she got really flushed and fell over. She did not hit anything off the floor, mom caught her. I (MA) ran to get provider to come check on her. Spo2 was taken 97 and blood pressure was taken 88/60 gave water/juice/and a snack had her lay down

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fall
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-